Investors / Spain / Columbus Venture Partners
Columbus Venture Partners
Venture capital · Valencia, Spain · Europe
Columbus Venture Partners is a Spanish venture capital firm that invests in biotechnology through life science funds. It invests in therapeutic and industrial products and combines therapeutic seed investing with infrastructure creation.
Invests inHealthcare & Biotech
In its own wordsbiotechlife sciencestherapeuticshealthcareseedindustrial biotech
Your fit with Columbus Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsColumbus Venture Partners lists 24 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 64% of its companies are based in Spain. It invests most often alongside Advent Life Sciences, Ysios Capital and AdBio partners.
No funding round on record names Columbus Venture Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not Columbus Venture Partners' whole history. Rounds on record name 0 companies; its own site lists 24. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 59th | 24 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 58th | 3 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2396%
- No longer answers00%
- Points to another company14%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Advent Life Sciences
Compare Columbus Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
24 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Accipiter Biosciences designs and develops protein therapies to address complex diseases. | Healthcare & Biotech | Portfolio page | ||
| Advanthera provides comprehensive drug supply, manufacturing, and lab support, led by experts in European regulations to ensure pipeline excellence | Healthcare & Biotech | Portfolio page | ||
| Aleta Biotherapeutics develops biologic therapies to enhance the effectiveness of CAR T cell therapies in treating cancer. | Healthcare & Biotech | Portfolio page | ||
| Algenex is a VC-backed technology company developing disruptive technologies to boost recombinant biologics production using proprietary technologies based on Baculovirus vector expression systems (BVES) in insect cells. | Healthcare & Biotech | Portfolio page | ||
| The company operates a pharmacy that delivers prescriptions and offers 24/7 support | Healthcare & Biotech | Portfolio page | ||
| Artax Biopharma develops treatments for autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| Arthex Biotech develops RNA medicine for diseases with unmet medical needs, including Myotonic Dystrophy. | Healthcare & Biotech | Portfolio page | ||
| Aura Biosciences is a clinical-stage biotechnology company that develops targeted oncology therapies for ocular cancers. | Healthcare & Biotech | Portfolio page | ||
| Cocoon manufactures recombinant proteins, including enzymes, using a unique expression system based on insects in a chrysalis state. | Healthcare & Biotech | Portfolio page | ||
| Curapath is a global CDMO specializing in GMP-manufactured polymer and lipid-based drug delivery systems from discovery to commercialization. | Healthcare & Biotech | Portfolio page | ||
| The company develops innovative cyclic peptide and small molecule drugs to treat diseases such as cancer, immunology and inflammation. | Healthcare & Biotech | Portfolio page | ||
| Highlight Therapeutics develops dermato-oncology treatments, including RNA-based therapies for skin cancers. | Healthcare & Biotech | Portfolio page | ||
| Integra Therapeutics is committed to create new gene writing tools that help to improve the scope, efficiency and safety of advanced therapies. | Healthcare & Biotech | Portfolio page | ||
| Jurata simplifies the supply chain for biologics, vaccines, and advanced therapeutics by creating thermostable formulations | Healthcare & Biotech | Portfolio page | ||
| Lark provides digital health coaching and personalized health programs for various health conditions, including diabetes, weight loss, and high blood pressure. | Healthcare & Biotech | Portfolio page | ||
| Lutris Pharma is a clinical-stage biopharmaceutical company developing novel topical therapies that may allow patients to stay on life-saving treatments. | Healthcare & Biotech | Portfolio page | ||
| Minoryx Therapeutics discovers and develops novel treatments for severe orphan diseases of the central nervous system | Healthcare & Biotech | Portfolio page | ||
| Quatre Lab provides comprehensive quality control services for ATMPs | Healthcare & Biotech | Portfolio page | ||
| Quibim designs pioneering tools that unlock imaging data to improve patient outcomes | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- columbusvp.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 24
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Columbus Venture Partners' profile as data
Pull Columbus Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/columbusvp.com
# also
GET /v1/firms/columbusvp.com/portfolio
GET /v1/firms/columbusvp.com/coinvestors
GET /v1/firms/columbusvp.com/news